Atrial fibrillation prevalence and atrial vulnerability analysis in paroxysmal supraventricular tachycardia patients after radiofrequency ablation.

نویسندگان

  • Q-X Zhao
  • Y-M Zhao
  • L Mao
  • D-L Shen
  • X-Y Zhao
چکیده

OBJECTIVE Paroxysmal supraventricular tachycardia (PSVT) patient has higher prevalence ratio of atrial fibrillation (AF), while AF recurrence remains a high ratio after radiofrequency ablation (RFCA). This study explored AF prevalence and atrial vulnerability in PSVT patients after RFCA, using ROC curve to analyze atrial effective refractory period dispersion (dERP) on postoperative AF in the prediction of PSVT. PATIENTS AND METHODS The PSVT patients were enrolled and divided into three groups and received RFCA treatment between January 2010 and December 2014. Group A, AF was induced by programmed electrical stimulation (PES) under isopropyl epinephrine (ISO) perfusion; group B, AF was induced by PES or PES under ISO perfusion; group C, no AF was generated by PES or PES under ISO perfusion. Ultrasonic cardiogram was applied to detect intra, inter, atrial electromechanical delay and dERP. ROC curve was adopted to analyze the prediction effect of dERP on postoperative AF recurrence. RESULTS dERP, group B > A > C; inter and intra: group B > A (p<0.05). Logistic regression analysis showed that age, gender, sympathetic nerve stimulation, and left/right atrial diameter were independent risk factors of postoperative AF in PSVT patients (p<0.05). Of note, dERP cut-off value at 75.5 msec can effectively predict AF recurrence in PSVT patients after RFCA (p<0.05). CONCLUSIONS Atrial vulnerability index dERP could be applied to evaluate AF recurrence in PSVT patients after RFCA.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

NASPE 25TH ANNIVERSARY SERIES Catheter Ablation of Supraventricular Arrhythmias: State of the Art

The era of catheter ablation for the treatment of arrhythmias began in 1981, when Dr. Melvin Scheinman performed the first atrioventricular junction ablation using direct-current shocks in a patient with drug-refractory atrial fibrillation and an uncontrolled ventricular rate.1 Because of the barotrauma associated with intracardiac high-energy shocks, direct-current catheter ablation played onl...

متن کامل

Catheter ablation of supraventricular arrhythmias: state of the art.

The era of catheter ablation for the treatment of arrhythmias began in 1981 when Dr. Melvin Scheinman performed the first atrioventricular junction ablation using direct current shocks in a patient with drug refractory atrial fibrillation and an uncontrolled ventricular rate.1 Because of the barotrauma associated with intracardiac, high energy shocks, direct current catheter ablation played onl...

متن کامل

Transition from atrioventricular node reentry tachycardia to atrial fibrillation begins in the pulmonary veins.

A37-year-old man with frequent episodes of paroxysmal atrial fibrillation refractory to antiarrhythmic therapy (and no other documented arrhythmias on multiple Holter examinations) underwent an attempt at radiofrequency ablation of the atrial fibrillation. Catheter positions are shown in the left anterior oblique view in Figure 1 and include 2 catheters in the left and right upper pulmonary vei...

متن کامل

Ibutilide for the Cardioversion of Paroxysmal Atrial Fibrillation during Radiofrequency Ablation of Supraventricular Tachycardias

Direct current electrical cardioversion (DC-ECV) is the preferred treatment for the termination of paroxysmal atrial fibrillation (AF) that occurs during radiofrequency ablation (RFA) of supraventricular tachycardias (SVT). Intravenous Ibutilide may be an alternative option in this setting. Thirty-four out of 386 patients who underwent SVT-RFA presented paroxysmal AF during the procedure and we...

متن کامل

Cryoballoon or Radiofrequency Ablation for Paroxysmal Atrial Fibrillation.

BACKGROUND Current guidelines recommend pulmonary-vein isolation by means of catheter ablation as treatment for drug-refractory paroxysmal atrial fibrillation. Radiofrequency ablation is the most common method, and cryoballoon ablation is the second most frequently used technology. METHODS We conducted a multicenter, randomized trial to determine whether cryoballoon ablation was noninferior t...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • European review for medical and pharmacological sciences

دوره 21 3  شماره 

صفحات  -

تاریخ انتشار 2017